These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts. Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z; Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129 [TBL] [Abstract][Full Text] [Related]
44. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Caroli A; Prestia A; Wade S; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Reiman EM; Jagust WJ; Frisoni GB; Alzheimer Dis Assoc Disord; 2015; 29(2):101-9. PubMed ID: 25437302 [TBL] [Abstract][Full Text] [Related]
45. Mild cognitive impairment: a clinically useful but currently ill-defined concept? Thompson SA; Hodges JR Neurocase; 2002; 8(6):405-10. PubMed ID: 12529449 [TBL] [Abstract][Full Text] [Related]
46. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
47. Progression to dementia in clinical subtypes of mild cognitive impairment. Alexopoulos P; Grimmer T; Perneczky R; Domes G; Kurz A Dement Geriatr Cogn Disord; 2006; 22(1):27-34. PubMed ID: 16679762 [TBL] [Abstract][Full Text] [Related]
48. Functional imaging in mild cognitive impairment and early Alzheimer's disease: is it pertinent? Ibáñez V; Deiber MP Front Neurol Neurosci; 2009; 24():30-38. PubMed ID: 19182460 [TBL] [Abstract][Full Text] [Related]
49. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H; Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517 [TBL] [Abstract][Full Text] [Related]
50. Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles. Park MH; Han C Int Psychogeriatr; 2015 Mar; 27(3):429-37. PubMed ID: 25255915 [TBL] [Abstract][Full Text] [Related]
51. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551 [TBL] [Abstract][Full Text] [Related]
52. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?]. Sarazin M; Dubois B Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583 [TBL] [Abstract][Full Text] [Related]
53. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey. García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544 [TBL] [Abstract][Full Text] [Related]